Management of End Stage Renal Disease-Bangladesh Perspective

Author:

Rashid Harun Ur

Abstract

End stage renal disease (ESRD) is an important cause of morbidity and mortality throughout the world. The treatment of renal replacement therapy (RRT) for patients with ESRD is expensive. There is a direct relationship between per capita income and treatment of ESRD. Eighty five per cent of the world’s population lives in low income or middle-income countries, where the mortality is highest in patients with chronic kidney disease. The future perspective is not satisfactory for Bangladesh where treatment of ESRD is out of reach for majority of people. Effort should made for prevention and treatment of CKD at an initial stage of disease.

Publisher

Bentham Science Publishers Ltd.

Subject

Urology,Nephrology

Reference12 articles.

1. Scheppati A, Peirco N, Remuzza G. Preventing end stage renal disease the potential impact of screening and intervention in developing countries. Nephrol Dial Transplant 2003; 18 : 858-9.

2. US Renal Data System USRDS 2012 Annual data report Atlas of chronic kidney disease and end stage renal disease in the United States. Bethesda MD National Institute Health National Institute of Diabetes and Digestive and Kidney Disease 2012.

3. Alam KS, Huda MN, Rashid HU, Saha M. Prevalence of diabetes mellitus, hypertension, proteinuria and association of these risk factors with estimated glomerular filtration rate (eGFR) in adult disadvantaged population. Bangladesh Renal J 2010; 29 (1) : 1-6.

4. Faroque MO, Rashid HU, Rahman MH, Alam MR, Islam S. Prevalence of diabetes mellitus, hypertension and proteinuria in a rural area of Bangladesh. Bangladesh Renal J 2010; 29 (1) : 7-11.

5. Hadiuzzaman KBM, Rahaman MH, Alam MR , et al. Prevalence of diabetes mellitus and hypertension in health service providers. Bangladesh Renal J 2010; 29 (1) : 12-5.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3